Logo image of TRAW

TRAWS PHARMA INC (TRAW) Stock Analyst Earnings Estimates

NASDAQ:TRAW - Nasdaq - US68232V8845 - Common Stock - Currency: USD

7.81  +0.14 (+1.83%)

After market: 8.16 +0.35 (+4.48%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
TRAW revenue by date.TRAW revenue by date.
226K
8.26%
226K226K234.6K
3.81%
234.6K306K
30.43%
EBITDA
YoY % growth
TRAW ebitda by date.TRAW ebitda by date.
-16.482M
36.13%
-19.613M
-19.00%
-20.282M
-3.41%
-23.97M
-18.18%
-29.172M
-21.70%
-33.864M
-16.08%
EBIT
YoY % growth
TRAW ebit by date.TRAW ebit by date.
-16.496M
33.67%
-19.627M
-18.98%
-20.298M
-3.42%
-144.343M
-611.12%
-32.557M
77.44%
-33.864M
-4.01%
Operating Margin
TRAW operating margin by date.TRAW operating margin by date.
-7,299.12%-8,684.51%-8,981.42%-61,527.39%-13,877.83%-11,066.67%
EPS
YoY % growth
TRAW eps by date.TRAW eps by date.
-0.94
51.79%
-0.91
3.19%
-0.90
1.10%
-157.44
-17,393.00%
-36.23
76.99%
-0.83
97.72%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-9.74
-5,026.84%
-8.20
-3,395.65%
-8.93
-3,400.00%
-9.34
-6.05%
-9.75
-0.10%
Revenue
Q2Q % growth
61.2K
9.29%
61.2K
9.29%
61.2K
7.37%
61.2K
7.37%
61.2K
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
N/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-8.81
-3,730.43%
-6.25-2.56-41.02%
Q2 2024
Q2Q % growth

-27.50%
-0.26%
Q1 2024
Q2Q % growth

16.21%
-0.23%
Q4 2023
Q2Q % growth
-0.19
26.92%
-0.260.0726.47%
Q3 2023
Q2Q % growth
-0.23
11.54%
-0.300.0722.24%
Q2 2023
Q2Q % growth
-0.20
-5.26%
-0.320.1237.25%
Q1 2023
Q2Q % growth
-0.28
-40.00%
-0.300.027.73%
Q4 2022
Q2Q % growth
-0.26
-73.33%
-0.290.038.96%
Q3 2022
Q2Q % growth
-0.26
-18.18%
-0.22-0.04-19.95%
Q2 2022
Q2Q % growth
-0.19
29.63%
-0.200.015.68%
Q1 2022
Q2Q % growth
-0.20
33.33%
-0.19-0.01-3.20%
Q4 2021
Q2Q % growth
-0.15
66.67%
-0.280.1345.53%
Q3 2021
Q2Q % growth
-0.22
51.11%
-0.330.1133.97%
Q2 2021
Q2Q % growth
-0.27
55.00%
-0.290.027.12%
Q1 2021
Q2Q % growth
-0.30
33.33%
-0.460.1634.64%
Q4 2020
Q2Q % growth
-0.45
92.49%
-0.540.0915.97%
Q3 2020
Q2Q % growth
-0.45
96.00%
-0.510.0611.76%
Q2 2020
Q2Q % growth
-0.60
93.33%
-0.46-0.14-30.72%
Q1 2020
Q2Q % growth
-0.45
97.67%
-0.840.3946.52%
Q4 2019
Q2Q % growth
-5.99 -3.77-2.22-58.79%
Q3 2019
Q2Q % growth
-11.25 -9.33-1.92-20.54%
Q2 2019
Q2Q % growth
-9.00 -12.583.5828.48%
Q1 2019
Q2Q % growth
-19.35 -15.84-3.51-22.19%
TRAW Yearly EPS VS EstimatesTRAW Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -50K -100K -150K
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
57K 59.16K-2.16K-3.65%
Q2 2024
Q2Q % growth
57K 61.2K-4.2K-6.86%
Q1 2024
Q2Q % growth
56K
-38.31%
61.2K-5.2K-8.50%
Q4 2023
Q2Q % growth
56K
-5.34%
66.637K-10.637K-15.96%
Q3 2023
Q2Q % growth
57K
-3.23%
70.635K-13.635K-19.30%
Q2 2023
Q2Q % growth
57K
-2.39%
70.635K-13.635K-19.30%
Q1 2023
Q2Q % growth

4.30%
90.78K%
Q4 2022
Q2Q % growth

-2.52%
59.16K%
Q3 2022
Q2Q % growth

8.29%
58.905K%
Q2 2022
Q2Q % growth

186.25%
58.395K%
Q1 2022
Q2Q % growth

42.22%
87.037K%
Q4 2021
Q2Q % growth

48.75%
60.69K%
Q3 2021
Q2Q % growth

-96.17%
54.397K%
Q2 2021
Q2Q % growth

-88.44%
20.4K%
Q1 2021
Q2Q % growth

-61.04%
61.2K%
Q4 2020
Q2Q % growth

-85.77%
40.8K%
Q3 2020
Q2Q % growth

73.47%
1.422M%
Q2 2020
Q2Q % growth

-65.03%
176.46K%
Q1 2020
Q2Q % growth

81.18%
157.08K%
TRAW Yearly Revenue VS EstimatesTRAW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2M 4M 6M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-36.43% -3193.1% 0% -2607.89%
Revenue0% 0% 0% 0.88%